SNDX — SYNDAX PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 249 SEC-registered investment managers reported holding SNDX (SYNDAX PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $2.39B across 109.29M shares. That is +11.0% by share count (+10.11M shares) versus the previous quarter, while reported value moved +4.0%. Ownership is concentrated: the five largest holders account for 28.3% of reported value and the top ten for 41.4%.
Compared with the prior quarter, 40 opened new positions, 94 added to existing stakes, 80 trimmed, 43 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of SYNDAX PHARMACEUTICALS INC (SNDX) include Kynam Capital Management, LP, BlackRock Inc, Vanguard Group, ranked by reported 13F value among the 455 institutional holders on this page.
SNDX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding SNDX
The superinvestors we track who report SNDX in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 133.65K | $2.51M | 0.34% | Hold |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 167 | 48.23M | $877.63M | -0.7% |
| Q2 2026 | 249 | 109.29M | $2.39B | +11.0% |
| Q1 2026 | 251 | 99.87M | $2.33B | -5.4% |
| Q4 2025 | 237 | 101.56M | $2.13B | +1.4% |
| Q3 2025 | 231 | 99.92M | $1.53B | -3.1% |
| Q2 2025 | 215 | 103.29M | $966.44M | +9.8% |
| Q1 2025 | 220 | 95.70M | $1.19B | +3.6% |
| Q4 2024 | 217 | 94.57M | $1.24B | +5.4% |
Over the 8 quarters shown, institutional share counts decreased 49% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+11.0%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.27M | $174.25M | 0.00% | Add | |
| 4.65M | $87.48M | 0.00% | Add | |
| 3.95M | $74.33M | 0.00% | Add | |
| 2.31M | $43.46M | 0.00% | Reduce | |
| 2.22M | $41.75M | 0.00% | Add | |
| 3.49M | $36.42M | 0.01% | Add | |
| 1.92M | $36.17M | 0.04% | Add | |
| 1.67M | $31.52M | 0.14% | Reduce | |
| 1.34M | $25.11M | 0.03% | Add | |
| 1.32M | $24.76M | 8.27% | Hold | |
| 1.15M | $21.54M | 0.01% | Reduce | |
| 1.01M | $18.94M | 0.00% | Reduce | |
| 857.90K | $16.13M | 0.00% | Reduce | |
| 812.58K | $15.28M | 2.96% | Reduce | |
| 748.80K | $14.08M | 0.02% | Reduce | |
| 636.17K | $11.96M | 0.00% | Hold | |
| 611.61K | $11.50M | 0.04% | Add | |
| 605.00K | $11.37M | 1.60% | Add | |
| 594.98K | $11.19M | 0.03% | Add | |
| 533.32K | $10.03M | 0.00% | Reduce | |
| 530.47K | $9.97M | 0.09% | Add | |
| 428.29K | $8.05M | 4.40% | Reduce | |
| 366.57K | $6.89M | 0.03% | Hold | |
| 364.48K | $6.85M | 0.00% | Reduce | |
| 345.10K | $6.49M | 0.07% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.02M | $197.18M | 0.00% | Add | |
| 8.05M | $175.99M | 9.73% | Hold | |
| 5.86M | $128.13M | 0.04% | Add | |
| 4.05M | $88.43M | 0.01% | Reduce | |
| 3.93M | $85.86M | 0.00% | Add | |
| 3.78M | $82.63M | 1.04% | Hold | |
| 2.80M | $61.17M | 3.20% | Reduce | |
| 2.58M | $56.50M | 0.00% | New | |
| 2.58M | $56.50M | 0.00% | Add | |
| 2.56M | $56.06M | 0.41% | Add | |
| 2.50M | $54.65M | 6.00% | Hold | |
| 2.29M | $49.98M | 0.01% | Add | |
| 2.05M | $44.90M | 0.02% | Add | |
| 2.05M | $44.90M | 0.06% | Add | |
| 1.92M | $42.01M | 0.00% | Add | |
| 1.89M | $41.40M | 0.02% | Add | |
| 1.85M | $40.55M | 10.19% | Hold | |
| 1.79M | $39.13M | 0.04% | Add | |
| 1.70M | $37.04M | 0.17% | Add | |
| 1.63M | $35.59M | 1.23% | Reduce | |
| 1.58M | $34.50M | 0.05% | Hold | |
| 1.54M | $33.71M | 0.68% | Add | |
| 1.36M | $29.83M | 0.01% | Reduce | |
| 1.33M | $29.15M | 1.78% | Reduce | |
| 1.32M | $28.79M | 6.10% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.25M | $192.82M | 0.01% | Hold | |
| 8.05M | $188.07M | 12.13% | Hold | |
| 5.00M | $116.72M | 0.04% | Reduce | |
| 4.43M | $103.49M | 0.00% | Reduce | |
| 4.25M | $99.28M | 0.01% | Reduce | |
| 3.82M | $89.30M | 0.00% | New | |
| 3.78M | $88.30M | 1.16% | New | |
| 2.89M | $67.41M | 3.60% | Reduce | |
| 2.50M | $58.40M | 6.56% | Add | |
| 2.35M | $55.00M | 0.55% | Add | |
| 2.16M | $50.40M | 0.00% | Add | |
| 2.15M | $50.23M | 0.01% | Reduce | |
| 1.99M | $46.38M | 0.19% | Reduce | |
| 1.85M | $43.33M | 12.30% | Hold | |
| 1.74M | $40.58M | 0.00% | New | |
| 1.73M | $40.47M | 0.05% | Add | |
| 1.73M | $40.34M | 1.63% | Reduce | |
| 1.60M | $37.42M | 0.02% | Add | |
| 1.60M | $37.42M | 0.07% | Add | |
| 1.58M | $36.90M | 0.06% | Add | |
| 1.49M | $34.91M | 0.01% | Add | |
| 1.34M | $31.32M | 2.42% | Hold | |
| 1.32M | $30.76M | 6.46% | Hold | |
| 1.25M | $29.22M | 0.11% | Hold | |
| 1.15M | $26.95M | 0.01% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.24M | $173.10M | 0.01% | Reduce | |
| 8.05M | $169.15M | 11.29% | Reduce | |
| 6.23M | $130.90M | 0.00% | Add | |
| 5.70M | $119.66M | 0.05% | Add | |
| 4.88M | $102.57M | 0.39% | Add | |
| 4.71M | $98.97M | 0.01% | Add | |
| 4.60M | $96.57M | 0.00% | Add | |
| 3.31M | $69.64M | 3.51% | Reduce | |
| 2.42M | $50.88M | 0.02% | Add | |
| 2.35M | $49.37M | 6.68% | Reduce | |
| 2.32M | $48.67M | 0.53% | New | |
| 2.25M | $47.21M | 1.74% | Add | |
| 2.09M | $43.94M | 0.00% | Hold | |
| 1.85M | $38.97M | 11.50% | New | |
| 1.60M | $33.59M | 0.06% | Add | |
| 1.48M | $31.16M | 0.01% | Hold | |
| 1.38M | $28.90M | 0.03% | Add | |
| 1.34M | $28.14M | 5.46% | Add | |
| 1.34M | $28.11M | 3.22% | Reduce | |
| 1.32M | $27.67M | 5.78% | Hold | |
| 1.25M | $26.28M | 0.10% | Reduce | |
| 1.24M | $26.01M | 0.41% | Add | |
| 1.22M | $25.62M | 0.01% | Add | |
| 1.22M | $25.62M | 0.05% | Add | |
| 1.20M | $25.14M | 4.44% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.63M | $132.70M | 0.00% | Reduce | |
| 8.52M | $131.08M | 9.76% | Hold | |
| 5.49M | $84.41M | 0.04% | Reduce | |
| 5.14M | $79.06M | 0.00% | Add | |
| 4.26M | $65.46M | 0.26% | Add | |
| 3.85M | $59.29M | 0.00% | Add | |
| 3.70M | $56.89M | 0.01% | Reduce | |
| 3.47M | $53.34M | 3.97% | Reduce | |
| 3.31M | $50.95M | 0.08% | Add | |
| 2.50M | $38.46M | 5.03% | Add | |
| 2.39M | $36.78M | 0.01% | Add | |
| 2.09M | $32.18M | 0.00% | Add | |
| 2.01M | $30.96M | 1.56% | Add | |
| 1.78M | $27.45M | 0.05% | Reduce | |
| 1.64M | $25.31M | 0.06% | Reduce | |
| 1.61M | $24.84M | 4.59% | Reduce | |
| 1.55M | $23.85M | 0.11% | Reduce | |
| 1.48M | $22.71M | 0.01% | Add | |
| 1.38M | $21.16M | 3.46% | New | |
| 1.32M | $20.27M | 4.44% | Hold | |
| 1.24M | $19.02M | 0.05% | Reduce | |
| 1.20M | $18.45M | 0.00% | Add | |
| 1.08M | $16.58M | 0.03% | Add | |
| 1.08M | $16.58M | 0.01% | Add | |
| 1.05M | $16.19M | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.46M | $97.93M | 0.00% | Add | |
| 8.52M | $79.79M | 8.59% | Hold | |
| 5.80M | $54.29M | 0.02% | Add | |
| 5.03M | $47.14M | 0.00% | Add | |
| 4.07M | $38.07M | 3.50% | Reduce | |
| 3.84M | $35.95M | 0.01% | Add | |
| 3.44M | $32.24M | 0.00% | Reduce | |
| 2.37M | $22.22M | 8.09% | Add | |
| 2.36M | $22.10M | 0.01% | Add | |
| 2.13M | $19.92M | 0.10% | Add | |
| 2.10M | $19.71M | 4.13% | Add | |
| 2.10M | $19.67M | 2.73% | Add | |
| 2.05M | $19.19M | 0.00% | Add | |
| 2.04M | $19.10M | 0.04% | Hold | |
| 1.89M | $17.73M | 0.09% | Hold | |
| 1.67M | $15.60M | 0.04% | Add | |
| 1.60M | $14.97M | 0.03% | Add | |
| 1.60M | $14.97M | 0.01% | Add | |
| 1.57M | $14.72M | 3.72% | Reduce | |
| 1.52M | $14.28M | 0.94% | Reduce | |
| 1.45M | $13.54M | 0.03% | Add | |
| 1.44M | $13.44M | 0.01% | Reduce | |
| 1.43M | $13.41M | 0.02% | Add | |
| 1.41M | $13.24M | 0.23% | Add | |
| 1.32M | $12.33M | 3.43% | Add |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.58M sh · $56.50M
- LOOMIS SAYLES & CO L P 923.62K sh · $20.19M
- Sixth Street Partners Management Company, L.P. 814.30K sh · $17.80M
- FIRST TRUST ADVISORS LP 456.70K sh · $9.98M
- Jump Financial, LLC 402.85K sh · $8.81M
- JUPITER ASSET MANAGEMENT LTD 366.57K sh · $8.01M
- Jones Hill Capital LP 340.00K sh · $7.43M
- Alyeska Investment Group, L.P. 308.51K sh · $6.74M
- Verition Fund Management LLC 304.94K sh · $6.67M
- MACKENZIE FINANCIAL CORP 280.08K sh · $6.12M
- Y-Intercept (Hong Kong) Ltd 212.71K sh · $4.65M
- SCHRODER INVESTMENT MANAGEMENT GROUP 115.21K sh · $2.51M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 4.43M sh · $103.49M
- Point72 Asset Management sold 1.99M sh · $46.38M
- Integral Health Asset Management, LLC sold 350.00K sh · $8.18M
- CPP Investments sold 229.60K sh · $5.36M
- ESSEX INVESTMENT MANAGEMENT CO LLC sold 198.99K sh · $4.65M
- Cinctive Capital Management LP sold 117.32K sh · $2.74M
- ExodusPoint Capital Management, LP sold 105.05K sh · $2.45M
- Yelin Lapidot Holdings Management Ltd. sold 96.30K sh · $2.25M
- TUDOR INVESTMENT CORP ET AL sold 69.06K sh · $1.61M
- Hudson Bay Capital Management LP sold 62.33K sh · $1.46M
- Marshall Wace sold 54.27K sh · $1.27M
- Neo Ivy Capital Management sold 53.15K sh · $1.24M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 9.27M | 9.02M | 8.25M | 8.24M | 8.63M | 10.46M | 8.54M | 9.03M | 8.24M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 4.65M | — | 4.43M | 4.60M | 3.85M | 3.44M | 3.97M | 3.92M | 3.77M | 3.62M | 4.82M | 5.02M | 3.60M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.95M | 3.93M | 3.82M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.31M | 2.58M | 2.16M | 2.09M | 2.09M | 2.05M | 2.02M | 1.97M | 1.98M | 1.91M | 1.78M | 1.54M | 1.36M | 1.32M | 1.23M | 1.10M | 968.13K | 907.86K | 855.41K | 764.63K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.22M | 1.92M | 1.74M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 3.49M | 2.29M | 2.15M | 2.42M | 2.39M | 2.36M | 2.06M | 1.77M | 1.76M | 1.56M | 1.50M | 1.35M | — | — | — | — | — | — | — | — |
| BNP Paribas Asset Management Holding S.A. | 1.92M | 1.79M | 1.73M | 1.38M | 1.24M | 1.45M | 1.22M | 1.02M | 787.78K | — | — | — | — | — | — | — | — | — | — | — |
| Candriam S.C.A. | 1.67M | 1.70M | 925.33K | 925.33K | 925.33K | 675.09K | 450.44K | 547.16K | 998.62K | 970.11K | 1.05M | 1.02M | 240.01K | — | — | — | — | — | — | — |
| LOOMIS SAYLES & CO L P | 1.34M | 923.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aisling Capital Management LP | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.02M | 1.02M | 1.02M | 1.02M | 1.02M | 1.02M | 1.02M | — | — | — | — | — | — | — |
| UBS Group AG | 1.15M | 1.89M | 1.15M | 72.30K | 72.30K | 1.44M | 1.72M | 20.00K | 146.44K | 125.15K | 269.81K | 290.80K | 19.80K | 112.72K | 108.31K | 172.78K | 285.53K | 316.68K | 215.16K | 140.52K |
| BNY Mellon | 1.01M | 1.04M | 1.00M | 1.09M | 1.05M | 237.10K | 229.76K | 224.26K | 221.50K | 291.83K | 245.36K | 230.86K | 227.50K | 234.98K | 211.72K | 192.48K | 189.19K | 167.19K | 176.39K | 166.57K |
| Nuveen, LLC | 857.90K | 1.36M | 1.49M | 1.48M | 1.48M | 266.04K | 224.15K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Prosight Management, LP | 812.58K | 1.20M | 770.00K | 665.00K | 1.00M | 1.08M | 609.25K | 620.00K | 554.10K | 551.54K | — | — | — | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 748.80K | 867.83K | 990.97K | 1.60M | 809.06K | 689.06K | 689.06K | 267.95K | 361.82K | 518.88K | 514.85K | 514.85K | 514.85K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 636.17K | 633.51K | 600.52K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 611.61K | 363.15K | 88.90K | — | 148.14K | 127.11K | 145.03K | 104.88K | 53.43K | — | — | — | 24.01K | — | — | — | — | — | — | — |
| APIS CAPITAL ADVISORS, LLC | 605.00K | 556.00K | 550.00K | 724.00K | 638.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PANAGORA ASSET MANAGEMENT INC | 594.98K | 546.52K | 249.41K | 125.10K | 155.32K | — | — | — | — | 82.85K | 237.01K | 174.14K | 91.50K | — | — | — | — | — | — | — |
| Morgan Stanley | 533.32K | 588.98K | 893.93K | 1.08M | 1.20M | 849.24K | 2.28M | 5.31M | 887.14K | 756.23K | 1.82M | 1.66M | 550.03K | 429.72K | 1.09M | 149.37K | 158.57K | 291.68K | 697.70K | 277.48K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SNDX?
As of 2026-Q2, 249 institutional funds reported holding SNDX (SYNDAX PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $2.39B.
How many shares of SNDX do institutions own?
13F filers reported 109.29M shares of SNDX, worth $2.39B in aggregate at the end of 2026-Q2.
Is institutional ownership of SNDX rising or falling?
Share counts moved +11.0% versus the prior quarter — accumulation.
Who are the top institutional holders of SNDX?
The largest 13F holders are Kynam Capital Management, LP, BlackRock Inc, Vanguard Group, Goldman Sachs Group, Bank of America Corp; the top 25 are ranked at the top of this page.
Who are the major shareholders of SYNDAX PHARMACEUTICALS INC?
The major shareholders of SYNDAX PHARMACEUTICALS INC (SNDX) by reported 13F value are Kynam Capital Management, LP, BlackRock Inc, Vanguard Group, Goldman Sachs Group, Bank of America Corp, among 455 institutional holders.
Which legendary investors own SNDX?
1 of the legendary investors tracked on HoldingsHub report SNDX (SYNDAX PHARMACEUTICALS INC) in their latest 13F filings, led by Torray Funds. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on SNDX?
1 tracked superinvestors hold SNDX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.